Quest Diagnostics (DGX) Revenue (2009 - 2026)

Quest Diagnostics has disclosed Revenue across 18 years of filings, most recently posting $3.0 billion for Q2 2026.

• In Q2 2026, Revenue rose 10.21% year-over-year to $3.0 billion; the TTM figure through Jun 2026 stood at $11.6 billion (up 9.87% YoY), while the FY2025 annual figure was $11.0 billion, up 11.78% from the prior year.
• Revenue came in at $3.0 billion for Q2 2026 at Quest Diagnostics, up from $2.9 billion in the prior quarter.
• In the past five years, Revenue ranged from a high of $3.0 billion in Q2 2026 to a low of $2.3 billion in Q4 2023.
• Average Revenue over 5 years is $2.6 billion, with a median of $2.5 billion recorded in 2022.
• Year-over-year, Revenue decreased 14.98% in 2022 and climbed 15.19% in 2025.
• Over 5 years, Revenue stood at $2.3 billion in 2022, then dropped by 1.93% to $2.3 billion in 2023, then increased by 14.55% to $2.6 billion in 2024, then rose by 7.06% to $2.8 billion in 2025, then grew by 8.45% to $3.0 billion in 2026.
• Per Business Quant data, the three most recent Revenue figures were $3.0 billion in Q2 2026, $2.9 billion in Q1 2026, and $2.8 billion in Q4 2025.